Format

Send to

Choose Destination
Haematologica. 2019 Aug 8. pii: haematol.2019.227033. doi: 10.3324/haematol.2019.227033. [Epub ahead of print]

Ile73Asn mutation in protein C introduces a new N-linked glycosylation site on the first EGF-domain of protein C and causes thrombosis.

Author information

1
Oklahoma Medical Research Foundation, Oklahoma City, USA.
2
Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems.
3
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
4
Oklahoma Medical Research Foundation, Oklahoma City, USA; ray-rezaie@omrf.org.

Abstract

Activated protein C exerts its anticoagulant activity by protein S-dependent inactivation of factors Va and VIIIa by limited proteolysis. We identified a venous thrombosis patient who has plasma protein C antigen level of 63% and activity levels of 44% and 23%, as monitored by chromogenic and clotting assays. Genetic analysis revealed the proband carries compound heterozygous mutations (c.344T>A, p.I73N and c.1181G>A, p.R352Q) in PROC. We individually expressed protein C mutations and discovered that thrombin-thrombomodulin activates both variants normally and the resulting activated protein C mutants exhibit normal amidolytic and proteolytic activities. However, while protein S-dependent catalytic activity of activated protein C-R352Q toward factor Va was normal, it was significantly impaired for activated protein C-I73N. These results suggest that the Ile to Asn substitution impairs interaction of activated protein C-I73N with protein S. This conclusion was supported by a normal anticoagulant activity for activated protein C-I73N in protein S-deficient but not in normal plasma. Further analysis revealed Ile to Asn substitution introduces a new glycosylation site on first EGF-like domain of protein C, thereby adversely affecting interaction of activated protein C with protein S. Activated protein C-R352Q only exhibited reduced activity in sub-physiological concentrations of Na+ and Ca2+, suggesting that this residue contributes to metal ion-binding affinity of the protease, with no apparent adverse effect on its function in the presence of physiological levels of metal ions. These results provide insight into the mechanism by which I73N/R352Q mutations in activated protein C cause thrombosis in proband carrying this compound heterozygous mutation.

KEYWORDS:

Activated Protein C; Blood Coagulation and Fibrinolysis; Glycosylation; Protein S; Venous Thrombosis

PMID:
31399531
DOI:
10.3324/haematol.2019.227033
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center